Vantage BioTrials Celebrates its 10th Anniversary

MONTREAL, April 18, 2017 – Establishing its core values on high professionalism and always delivering accurate results, Vantage BioTrials is happy to announce its 10th anniversary.  This important milestone is a sign of recognition from all our partners for the quality of our Phase I-IV clinical trial management services, delivered to international organizations throughout the world. “Our 10th anniversary marks a crucial milestone in our existence and I would like to thank our clients, part...
Read More

Vantage BioTrials Awarded “Excellence in Phase I-IV Clinical Trial Management Services”

November 21, 2016, Montréal, Canada – Vantage BioTrials has yet again been awarded for its passion and commitment in providing its clients and patients quality clinical trial management through the recognition of Corporate LiveWire Magazine in the category of Excellence in Phase I-IV Clinical Trial Management Services in their 2016 Healthcare and Life Sciences Award series. “After winning the International Life Sciences Award earlier this year, this new award was not anticipated but highly...
Read More

Vantage BioTrials Awarded “Best for Phase I-IV Clinical Trial Management Services”

August 19, 2016, Montréal, Canada – We are very elated to announce that Vantage BioTrials has been recognized by Global Health & Pharma Magazine as Best for Phase I-IV Clinical Trial Management Services in their 2016 International Life Sciences Awards series. “This award is yet another milestone recognizing the exceptional work & quality that Vantage BioTrials has become known for within our industry.” said Vatche Bartekian, President of Vantage BioTrials.  Bartekian continued t...
Read More

A Synthesis of Adaptive Designs in Clinical Trials

A Synthesis of Adaptive Designs in Clinical Trials Publication date: May 2016 / Download PDF Author: Roy Nitulescu, Agnihotram V Ramanakumar, and Vatché Bartekian Abstract Since 2006, when the adaptive design working group presented their work in Washington D.C., the literature on adaptive designs has greatly expanded. Some designs have emerged as inherently better suited to exploratory-phase trials, while others are more appropriate for confirmatory phases of drug development. This article pro...
Read More

Vantage BioTrials Organizes International Clinical Research Conference and Makes the Patient’s Voice Heard

March 7, 2016, Montréal, Canada – Vantage BioTrials, in conjunction with the Clinical Research Association of Canada (CRAC), has become the first Contract Research Organization (CRO) to proudly organize a unique global conference being held on May 25-26, 2016 in Montréal.  With only two months left before the conference, “Canada Talks Pharma 2016:  A New Way Forward in Clinical Trials” is the first event of its kind showcasing new innovations and ideas on how to conduct the clinical tr...
Read More

Vantage BioTrials becomes Newest Member of Innovative Medicines Canada

February 10, 2016, Montréal, Canada – It is with pleasure that we announce the acceptance of Vantage BioTrials’ application for membership in the category of Life Sciences Associate Member by Innovative Medicines Canada (formerly Rx&D). Through a model of advocacy and collaboration, Innovative Medicines Canada, and its members, work together with government and health stakeholders to improve the Canadian environment for innovation of and access to patented pharmaceuticals and ensure the...
Read More

Vantage BioTrials’ President Nominated For Entrepreneur of the Year

July 13, 2015, Montréal, Canada – It is with pleasure to announce that Vantage BioTrials’ President, Vatché Bartekian, has been nominated by Ernst & Young for Entrepreneur of the Year 2015 in recognition of his vision, leadership and achievement in building a successful, growing and dynamic business. “It is a great honor to be recognized by our peers, clients, colleagues and partners through this prestigious nomination.  Ernst & Young is a beacon of quality amongst the business...
Read More

Quality by Design and Risk-Based Monitoring

Quality by Design and Risk-Based Monitoring Publication Date: February 2015 / Download PDF Authors: Ibtissem Triki and Vanessa Towers Brief Background Over the past decade, the clinical research industry’s standard to meet regulatory monitoring obligations has involved frequent and regular onsite monitoring visits with 100% source data verification (SDV). The belief that “more is better” continues even with new evidence that on-site monitoring practices do not necessarily guarantee patient...
Read More

Quality by Design in Clinical Research

Quality by Design in Clinical Research Publication date: May 2015 Originally published in Journal of Clinical Research Best Practices, Vol. 11, No. 5, May 2015Author: Vatche Bartekian “Quality is never an accident. It is always the result of high intention, sincere effort, intelligent direction, and skillful execution.” – William A. Foster In clinical research, “high quality” means that a study generates good, useful data, does not harm the study participants, and proceeds smoothly wi...
Read More

Clinical Trial Management: Houston, We Have a Problem

Clinical Trial Management: Houston, We Have a Problem Publication Date: April 2015 / Download as PDFAuthor: Reginald Exume In the management of clinical trials, whether they be local, international, multi-site, simple or complex, a variety of situations can (or should I say will) occur that will have you saying “Houston, we have a problem!” These complications may be related to an issue at the clinical site itself, within the CRO or at the Sponsor level, but could also be caused by the study...
Read More
EN